Prognostic significance of Lens culinaris agglutinin A-reactive alpha-fetoprotein in small hepatocellular carcinomas

被引:179
作者
Yamashita, F
Tanaka, M
Satomura, S
Tanikawa, K
机构
[1] KURUME UNIV,SCH MED,DEPT MED 2,KURUME,FUKUOKA 830,JAPAN
[2] WAKO PURE CHEM IND LTD,OSAKA RES LABS,AMAGASAKI,HYOGO,JAPAN
关键词
D O I
10.1016/S0016-5085(96)70067-7
中图分类号
R57 [消化系及腹部疾病];
学科分类号
摘要
Background & Aims: Lens culinaris agglutinin A-reactive fraction of alpha-fetoprotein (AFP-L3) has been reported to be a useful marker in the early diagnosis of hepatocellular carcinoma (HCC), The aim of this study was to evaluate the prognostic value of AFP-L3 for HCC, Methods: Fifty-five patients with HCC whose AFP-L3 levels were negative before initial therapy were studied, AFP-L3 levels were measured by lectin-affinity electrophoresis coupled with antibody-affinity blotting. Results: Of the 55 patients, 28, 15, and 12 underwent percutaneous ethanol injection, transcatheter arterial embolization, and hepatectomy, respectively. Thirty-two (58.2%) of the 55 patients maintained a negative AFP-L3 status during the study, and 23 patients (41.8%) became positive for AFP-L3 during posttreatment observation, Multiple recurrences of HCC and portal vein tumor thrombus were observed significantly more often in patients with positive AFP-L3 than in those with negative AFP-LS status (P < 0.0001). In contrast, most patients with negative AFP-LB had solitary recurrences of HCC without portal vein tumor thrombus, Overall survival was significantly lower in patients with positive AFP-L3 than in those with negative AFP-LB status (P = 0.0006), Cox's proportional hazards model identified that AFP-LB was an independent prognostic factor (P = 0.0005), Conclusions: AFP-L3 seems to be a significant marker of poor prognosis for HCC.
引用
收藏
页码:996 / 1001
页数:6
相关论文
共 46 条
[1]  
[Anonymous], HEPATOCELLULAR CARCI
[2]   FUCOSYLATION OF SERUM ALPHA-FETOPROTEIN IN PATIENTS WITH PRIMARY HEPATOCELLULAR-CARCINOMA [J].
AOYAGI, Y ;
ISEMURA, M ;
YOSIZAWA, Z ;
SUZUKI, Y ;
SEKINE, C ;
ONO, T ;
ICHIDA, F .
BIOCHIMICA ET BIOPHYSICA ACTA, 1985, 830 (03) :217-223
[3]  
AOYAGI Y, 1988, CANCER-AM CANCER SOC, V61, P769, DOI 10.1002/1097-0142(19880215)61:4<769::AID-CNCR2820610422>3.0.CO
[4]  
2-M
[5]  
AOYAGI Y, 1986, LANCET, V1, P210
[6]   AFLATOXIN-B1 DNA ADDUCTS IN SMEARED TUMOR-TISSUE FROM PATIENTS WITH HEPATOCELLULAR-CARCINOMA [J].
CHEN, CJ ;
ZHANG, YJ ;
LU, SN ;
SANTELLA, RM .
HEPATOLOGY, 1992, 16 (05) :1150-1155
[7]  
Child CG III, 1964, LIVER PORTAL HYPERTE, P49
[8]   HEPATOCELLULAR-CARCINOMA AND PORTAL-VEIN INVASION - RESULTS OF TREATMENT WITH TRANSCATHETER OILY CHEMOEMBOLIZATION [J].
CHUNG, JW ;
PARK, JH ;
HAN, JK ;
CHOI, BI ;
HAN, MC .
AMERICAN JOURNAL OF ROENTGENOLOGY, 1995, 165 (02) :315-321
[9]  
COLOMBO M, 1993, SEMIN LIVER DIS, V13, P374
[10]  
COX DR, 1972, J R STAT SOC B, V34, P187